Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Belén Saavedra, Edson Mambuque, Dinis Nguenha, Neide Gomes, Shilzia Munguambe, Juan Ignacio García, Santiago Izco, Sozinho Acacio, Adrià Murias-Closas, Marta Cossa, Irene Losada, Hadrián Pernas-Pardavila, Laura Oliveras, Grant Theron, Alberto L. García-Basteiro. Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding. Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021

Member's Comments

No comment yet.

Related content which might interest you: Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012 A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018 Year: 2019 Effect of history of tuberculosis on specificity of Xpert MTB/RIF Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020 Year: 2020 Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013 Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014 Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting Source: Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017 Year: 2018 Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF Source: Eur Respir J 2013; 42: 252-271 Year: 2013 Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018 Year: 2018 Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis Source: Eur Respir J 2013; 42: 1427-1429 Year: 2013 Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Source: Eur Respir J 2015; 45: 549-554 Year: 2015